Cardiac fatty acid uptake and transport in health and disease

Cardiovascular Research

Volumn 45, Issue 2, 2000, Pages 279-293

  Van Der Vusse, Ger J ^a   Van Bilsen, Marc ^a   Glatz, Jan F C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cardiomyopathy; Diabetes; Energy metabolism; Heart failure; Hypertrophy

Indexed keywords

FATTY ACID; FATTY ACID BINDING PROTEIN; LONG CHAIN FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYUNSATURATED FATTY ACID;

DIABETES MELLITUS; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENE CONTROL; HEART FAILURE; HEART HYPERTROPHY; HUMAN; LIPID METABOLISM; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL TRANSPORT; CARDIOMEGALY; CARDIOMYOPATHIES; CARRIER PROTEINS; DIABETES MELLITUS; FATTY ACIDS; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA, HEART; MYOCARDIUM;

EID: 0033959905     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00263-1     Document Type: Review

References (136)

1. Van der Vusse G.J., Glatz J.F.C., Stam H.C.G., Reneman R.S. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev. 72:1992;881-940.
2. Van Bilsen M., Van der Vusse G.J., Reneman R.S. Transcriptional regulation of metabolic processes: implications for cardiac metabolism. Eur J Physiol. 437:1998;2-14.
3. Bassingthwaighte J.B., Noodleman L., Van der Vusse G.J., Glatz J.F.C. Modeling of palmitate transport in the heart. Mol Cell Biochem. 88:1989;51-58.
4. Van der Vusse G.J., Glatz J.F.C., Van Nieuwenhoven F.A., Reneman R.S., Bassingthwaighte J.B. Transport of long-chain fatty acids across the muscular endothelium. Adv Exp Med Biol. 441:1998;181-191.
5. Spener F., Börchers T. Structural and multifunctional properties of cardiac fatty acid-binding protein: from fatty acid binding to cell growth inhibition. Biochem Soc Trans. 20:1992;806-811.
6. Veerkamp J.H., Maatman R.G.H.J. Cytoplasmic fatty acid-binding proteins: their structure and genes. Prog Lipid Res. 34:1995;17-52.
7. Schaffer J.E., Lodish H.F. Molecular mechanism of long-chain fatty acid uptake. Trends Cardiovasc Med. 5:1995;218-224.
8. Fitscher B.A., Elsing C., Riedel H.-D., Górski J., Stremmel W. Protein-mediated facilitated uptake processes for fatty acids, bilirubin, and other amphipathic compounds. Proc Soc Exp Biol Med. 212:1996;15-23.
9. Glatz J.F.C., Van der Vusse G.J. Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res. 35:1996;243-282.
10. Van Bilsen M., De Vries J.E., Van der Vusse G.J. Long-term effects of fatty acids on cell viability and gene expression of neonatal cardiac myocytes. Prostagl Leukotr Essent Fatty Acids. 57:1997;39-45.
11. Tanaka T., Okamoto F., Sohmiya K., Kawamura K. Lack of myocardial iodine-123 15-(-p-iodiphenyl)-3-R, S-methylpentadecanoic acid (BMIPP) uptake and CD36 abnormality. CD36 deficiency and hypertrophic cardiomyopathy. Jpn Circ J. 61:1997;724-725.
12. Tanaka T., Sohmiya K., Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol. 29:1997;121-127.
13. Bing R.J., Siegel A., Ungar I., Gilbert M. Metabolism of the heart. II. Studies on fat, ketone and amino acid metabolism. Am J Med. 16:1954;504-515.
14. Neely J.H., Morgan H.E. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol. 36:1974;413-459.
15. Taegtmeyer H. Carbohydrate interconversions and energy production. Circulation. 72:(Suppl. IV):1985;1-8.
16. Drake A.J., Haines J.R., Noble M.I.M. Preferential uptake of lactate by the normal myocardium in dogs. Cardiovasc Res. 14:1980;65-72.
17. Van der Vusse G.J., Reneman R.S. Glycogen and lipids (endogenous substrates). Drake-Holland A.J., Noble M.I.M. Cardiac metabolism. 1983;215-237 Wiley, Chicester.
18. Van der Vusse G.J., Roemen T.H.M., Prinzen F., Coumans W.A., Reneman R.S. Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischemic conditions. Circ Res. 50:1982;538-546.
19. Ailhaud G.P., Abumrad N., Amri E.Z., Grimaldi P.A. A new look at fatty acids as signal-transducing molecules. World Rev Nutr Diet. 75:1994;35-45.
20. Van der Vusse G.J., Roemen T.H.M. Protein acylation in normoxic and ischemic/reperfused cardiac tissue. Prostagl Leukotr Essent Fatty Acids. 60:1999;299-305.
21. Brandt J.M., Djouadi F., Kelly D.P. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem. 273:1998;23786-23792.
22. Linssen M.C.J.G., Engels W., Lemmens P.J.M.R., et al. Production of arachidonic acid-metabolites in adult rat cardiac myocytes, endothelial cells and fibroblast-like cells. Am J Physiol. 264:1993;H973-H982.
23. Karmazyn M., Dhalla N.S. Physiological and pathophysiological aspects of cardiac prostaglandins. Can J Physiol Pharmacol. 61:1983;1207-1225.
24. Oudot F., Grynberg A., Sergiel J.P. Eicosanoid synthesis in cardiomyocytes: influence of hypoxia, reoxygenation, and polyunsaturated fatty acids. Am J Physiol. 268:1995;H308-H315.
25. Cryer A. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism. Int J Biochem. 13:1981;525-541.
26. Cryer A. The role of the endothelium in myocardial lipoprotein dynamics. Mol Cell Biochem. 88:1989;7-15.
27. Carlson L.A., Kayser L., Rössner S., Wahlqvist M.L. Myocardial metabolism of exogenous plasma triglycerides. Acta Med Scand. 193:1973;233-245.
28. Wang X., Hole D.G., Da Costa T.H.M., Evans R.D. Alterations in myocardial lipid metabolism during lactation in the rat. Am J Physiol. 275:1998;E265-E271.
29. Van der Vusse G.J., Little S.E., Bassingthwaighte J.B. Transendothelial transport of arachidonic and palmitic acid in the isolated rabbit heart. J Mol Cell Cardiol. 19:(Suppl):1987;S100. Abstract.
30. Scow R.O., Blanchette-Mackie E.J., Smith L.C. Transport of lipid across capillary endothelium. Fed Proc. 39:1980;2610-2617.
31. Glatz J.F.C., Van der Vusse G.J. Cellular fatty acid-binding proteins: current concepts and future directions. Mol Cell Biochem. 98:1990;247-251.
32. Zakim D. Fatty acids enter cells by simple diffusion. Proc Soc Exp Biol Med. 212:1996;5-14.
33. Hamilton J.A. Fatty acid transport: difficult or easy? J Lipid Res. 39:1998;467-481.
34. Abumrad N., Harmon C., Ibrahimi A. Membrane transport of long-chain fatty acids: evidence for a facilitated process. J Lipid Res. 39:1998;2309-2318.
35. Rose H., Hennecke T., Kammermeier H. Sarcolemmal fatty acid transfer in isolated cardiomyocytes governed by albumin/membrane lipid partition. J Mol Cell Cardiol. 22:1990;883-892.
36. Berk P.D. How do long-chain free fatty acids cross cell membranes? Proc Soc Exp Biol Med. 212:1996;1-4.
37. Glatz J.F.C., Luiken J.J.F.P., Van Nieuwenhoven F.A., Van der Vusse G.J. Molecular mechanism of cellular uptake and intracellular translocation of fatty acids. Prostagl Leukotr Essent Fatty Acids. 57:1997;3-9.
38. Kamp F., Hamilton J.A. Movement of fatty acids, fatty acid analogues, and bile acids across phospholipid bilayers. Biochemistry. 32:1993;11074-11086.
39. Kamp F., Zakim D., Zhang F., Noy N., Hamilton J.A. Fatty acid flip-flop in phospholipid bilayers is extremely fast. Biochemistry. 34:1995;11928-11937.
40. Trigatti B.L., Gerber G.E. The effect of intracellular pH on long-chain fatty acid uptake in 3T3-L1 adipocytes: evidence that uptake involves the passive diffusion of protonated long-chain fatty acids across the plasma membrane. Biochem J. 313:1996;487-494.
41. Stremmel W., Strohmeyer G., Borchard F., Kochwa S., Berk P.D. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci USA. 82:1985;4-8.
42. Stump D.D., Zhou S.L., Berk P.D. Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am J Physiol. 265:1993;G894-G902.
43. Sorrentino D., Stump D.D., Potter B.J., et al. Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kDa plasma membrane fatty acid binding protein similar to that in liver, adipose tissue and gut. J Clin Invest. 82:1988;928-935.
44. Isola L.M., Zhou S.L., Kiang C.L., et al. 3T3 fibroblasts transfected with a cDNA for mitochondrial aspartate aminotransferase express plasma membrane fatty acid-binding protein and saturable fatty acid uptake. Proc Natl Acad Sci USA. 92:1995;9866-9870.
45. Abumrad N.A., El-Maghrabi M.R., Amri E.-Z., Lopez E., Grimaldi P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J Biol Chem. 268:1993;17665-17668.
46. Pearce S.F., Wu J., Silverstein R.L. A carboxyl terminal truncation mutant of CD36 is secreted and binds thrombospondin. Evidence for a single transmembrane domain. Blood. 84:1994;384-389.
47. Van Nieuwenhoven F.A., Willemsen P.M., Van der Vusse G.J., Glatz J.F.C. Coexpression in rat heart and skeletal muscle of four genes coding for proteins implicated in long-chain fatty acid uptake. Int J Biochem Cell Biol. 31:1999;489-498.
48. Sfeir Z., Ibrahimi A., Amri E., Grimaldi P., Abumrad N. Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport. Prostagl Leukotr Essent Fatty Acids. 57:1997;17-21.
49. Ibrahimi A., Sfeir Z., Magharaie H., et al. Expression of the CD36 homolog FAT in fibroblast cells: Effects on fatty acid transport. Proc Natl Acad Sci USA. 93:1996;2646-2651.
50. Schaffer J.E., Lodish H.F. Expression, cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 79:1994;427-436.
51. Schaap F.G., Hamers L., Van der Vusse G.J., Glatz J.F. Molecular cloning of fatty acid-transport protein cDNA from rat. Biochim Biophys Acta. 1354:1997;29-34.
52. Fujii S., Kawaguchi H., Yasuda H. Purification of high affinity fatty acid receptors in rat myocardial sarcolemmal membranes. Lipids. 22:1987;544-546.
53. Richieri G.V., Anel A., Kleinfeld A.M. Interactions of long-chain fatty acid and albumin: Determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry. 32:1993;7574-7580.
54. Schnitzer J.E., Sung A., Horvat R., Bravo J. Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism. J Biol Chem. 34:1992;24544-24553.
55. Tiruppathi C., Finnegan A., Malik A.B. Isolation and characterization of a cell surface albumin-binding protein from vascular endothelial cells. Proc Natl Acad Sci USA. 93:1996;250-254.
56. Popov D., Hasu M., Ghinea N., Simionescu N., Simionescu M. Cardiomyocytes express albumin binding proteins. J Mol Cell Cardiol. 24:1992;989-1002.
57. Scheider W. The rate of access to the organic ligand-binding region of serum albumin is entropy controlled. Proc Natl Acad Sci USA. 76:1979;2283-2287.
58. Svenson A., Holmer E., Anderson L.O. A new method for the measurement of dissociation rates for complexes between small ligands and proteins as applied to the palmitate and bilirubin complexes with serum albumin. Biochim Biophys Acta. 342:1974;54-59.
59. Goresky G.A., Stremmel W., Rose C.P., et al. The capillary transport system for free fatty acids in the heart. Circ Res. 74:1994;1015-1026.
60. Greenwalt D.W., Scheck S.H., Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest. 96:1995;1382-1388.
61. Linssen M.C.J.G., Vork M.M., De Jong Y.F., Glatz J.F.C., Van der Vusse G.J. Fatty acid oxidation capacity and fatty acid-binding protein content of different cell types isolated from rat heart. Mol Cell Biochem. 98:1990;19-26.
62. Van Nieuwenhoven F.A., Verstijnen C.P.H.J., Van Eijs G.J.J.M., et al. Fatty acid transfer across the myocardial capillary wall: No evidence for a substantial role of cytoplasmic fatty acid-binding protein. J Mol Cell Cardiol. 26:1994;1635-1647.
63. Vork M.M., Glatz J.F.C., Van der Vusse G.J. Modeling intracellular fatty acid transport: possible mechanistic role of cytoplasmic fatty acid-binding protein. Prostagl Leukotr Essent Fatty Acids. 57:1997;11-16.
64. Massouyé I., Hagens G., Van Kuppeveldt T.H., et al. Endothelial cells of the human microvasculature express epidermal fatty acid-binding proteins. Circ Res. 81:1997;297-303.
65. Antohe F., Popov D., Radulescu L., et al. Heart microvessels and aortic endothelial cells express the 15 kDa heart-type fatty acid-binding proteins. Eur J Cell Biol. 76:1998;102-109.
66. Luiken J.J.F.P., Van Nieuwenhoven F.A., America G., Van der Vusse G.J., Glatz J.F.C. Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: Involvement of sarcolemmal proteins. J Lipid Res. 38:1997;745-758.
67. Harmon C.M., Abumrad N.A. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: Isolation and amino-terminal sequence of an 88-kDa protein implicated in transport of long-chain fatty acids. J Membr Biol. 133:1993;43-49.
68. Luiken J.J.F.P., Turcotte L.P., Bonen A. Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J Lipid Res. 40:1999;1007-1016.
69. Bonen A., Luiken J.J.F.P., Liu S., et al. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol. 275:1998;E471-E478.
70. Richieri G.V., Ogata R.T., Kleinfeld A.M. Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J Biol Chem. 269:1994;23918-23930.
71. Baillie A.G.S., Coburn C.T., Abumrad N.A. Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog. J Membr Biol. 153:1996;75-81.
72. Peeters R.A., Veerkamp J.H., Demel R.A. Are fatty acid-binding proteins involved in fatty acid transfer? Biochim Biophys Acta. 1002:1989;8-13.
73. Vork M.M., Glatz J.F.C., Van der Vusse G.J. On the mechanism of long chain fatty acid transport in cardiomyocytes as facilitated by cytoplasmic fatty acid-binding protein. J Theor Biol. 160:1993;207-222.
74. Banaszak L., Winter N., Xu Z., Bernlohr D.A., et al. Lipid-binding proteins: a family of fatty acid and retinoid transport proteins. Adv Protein Chem. 45:1994;89-151.
75. Schaap F.G., Van der Vusse G.J., Glatz J.F.C. Fatty acid-binding proteins in the heart. Mol Cell Biochem. 180:1998;43-51.
76. Vork M.M., Glatz J.F.C., Surtel D.A.M., Knubben H.J.M., Van der Vusse G.J. A sandwich enzyme linked immunosorbent assay for the determination of rat heart fatty acid-binding protein using the streptavidin-biotin system. Application to tissue and effluent samples from normoxic rat heart perfusion. Biochim Biophys Acta. 1075:1991;199-205.
77. Börchers T., Unterberg C., Rudel H., Robenek H., Spener F. Subcellular distribution of cardiac fatty acid-binding protein in bovine heart muscle and quantitation with an enzyme-linked immunosorbent assay. Biochim Biophys Acta. 1002:1989;54-61.
78. Glatz J.F.C., Van Breda E., Van der Vusse G.J. Intracellular transport of fatty acids in muscle. Role of cytoplasmic fatty acid-binding protein. Adv Exp Med Biol. 441:1998;207-218.
79. Knudsen J., Mandrup S., Rasmussen J.T., et al. The function of acyl-CoA-binding protein (ACBP)/diazepam binding inhibitor (DBI). Mol Cell Biochem. 123:1993;129-138.
80. Binas B., Danneberg H., McWhir J., Mullins L., Clark A.J. Requirement for the heart-type fatty acid-binding protein in cardiac fatty acid utilization. FASEB J. 13:1999;805-812.
81. Schaap F.G., Danneberg H., Binas B., Van der Vusse G.J., Glatz J.F.C. Impaired uptake and oxidation of long-chain fatty acids by cardiac myocytes of mice lacking the heart-type fatty acid-binding protein (H-FABP) gene. Circ Res. 85:1999;329-337.
82. Spitsberg V.L., Matiatashvili E., Gorewit R.C. Association and coexpression of fatty-acid protein and glycoprotein CD36 in the bovine mammary gland. Eur J Biochem. 230:1995;872-878.
83. Kelly D.P., Strauss A.W. Inherited cardiomyopathies. New Engl J Med. 330:1994;913-919.
84. Lopaschuk G.D., Gamble J. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart. Can J Physiol Pharmacol. 72:1994;1101-1109.
85. Rodrigues B., McNeill J.H. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res. 26:1992;913-922.
86. Rupp H., Jacob R. Metabolically-modulated growth and phenotype of the rat heart. Eur Heart J. 13:1992;56-61.
87. Lopaschuk G.D., Belke D.D., Gamble J., Itoi T., Schonekess B.O. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta. 1213:1994;263-276.
88. Taroni F., Verderio E., Fiorucci S., et al. Molecular characterizaiton of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci USA. 89:1992;8429-8433.
89. Stanley C.A., Hale D.E., Barry G.T., et al. A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. New Engl J Med. 327:1992;19-23.
90. Yamaguchi S., Indo Y., Coates P.M., Hashimoto T., Tanaka K. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res. 34:1993;111-113.
91. Hale D.E., Batshaw M., Coates P.M., et al. Long chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of non-ketotic hypoglycemia. Pediatr Res. 19:1985;666-671.
92. Paulson D.J. The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res. 34:1997;104-112.
93. Stanley W.C., Lopaschuk G.D., McCormack J.G. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res. 34:1997;25-33.
94. Veerkamp J.H., Van Moerkerk H.T., Van den Born J. No correlation between changes in fatty acid-binding protein content and fatty acid oxidation capacity of rat tissues in experimental diabetes. Int J Biochem Cell Biol. 28:1996;473-478.
95. Glatz J.F.C., Van Breda E., Keizer H.A., et al. Rat heart fatty acid-binding protein content is increased in experimental diabetes. Biochem Biophys Res Commun. 199:1994;639-646.
96. Engels W., Van Bilsen M., Wolffenbuttel B.H.R., Van der Vusse G.J., Glatz J.F.C. Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat. Mol Cell Biochem. 192:1999;53-61.
97. Van Nieuwenhoven F.A., Van der Vusse G.J., Glatz J.F.C. Membrane-associated and cytoplasmic fatty acid-binding proteins. Lipids. 31:1996;S223-S227.
98. Pelsers M.M.A.L., Lutgerink J.T., Van Nieuwenhoven F.A., et al. A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes. Biochem J. 337:1999;407-414.
99. Heyliger C.E., Scarim A.L., Eymer V.P., Skau K.A., Powell D.M. Characteristics of the myocardial PM-FABP: Effect of diabetes mellitus. Mol Cell Biochem. 176:1997;281-286.
100. 125I-BMIPP. Nippon Igaku Hoshasen Gakkai Zasshi. 56:1996;137-138.
101. 123I-heptadecanoic acid in subjects with impaired glucose tolerance. Diabetologia. 40:1997;541-549.
102. Nugent A.M., Steele I.C., Al-Modaris F., et al. Exercise responses in patients with IDDM. Diabetes Care. 20:1997;1814-1821.
103. 1 and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc Natl Acad Sci USA. 94:1997;6438-6443.
104. Kagaya Y., Kanno Y., Takeyama D., et al. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. Circulation. 81:1990;1353-1361.
105. Allard M.F., Schonekess B.O., Henning S.L., English D.R., Lopaschuk G.D. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol. 267:1994;H742-H750.
106. El Alaoui-Talibi Z., Landormy S., Loireau A., Moravec J. Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts. Am J Pysiol. 2623:1992;H1068-H1074.
107. El Alaoui-Talibi Z., Guendouz A., Moravec M., Moravec J. Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine. Am J Physiol. 272:1997;H1615-H1624.
108. Pierpont M.E., Foker J.E., Pierpont G.L. Myocardial carnitine metabolism in congestive heart failure induced by incessant tachycardia. Basic Res Cardiol. 88:1993;362-370.
109. Regitz V., Bossaller C., Strasse R., et al. Metabolic alterations in end-stage and less severe heart failure - myocardial carnitine decrease. J Clin Chem Clin Biochem. 28:1990;611-617.
110. Masumura Y., Kobayashi A., Yamazaki N. Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure. Jpn Circ J. 54:1990;1471-1476.
111. Sack M.N., Rader T.A., Park S., Bastin J., McCune S.A., Kelly D.P. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 94:1996;2837-2842.
112. Vork M.M., Trigault N., Snoeckx L.H.E.H., Glatz J.F.C., Van der Vusse G.J. Heterogeneous distribution of fatty acid-binding protein in the hearts of Wistar Kyoto and spontaneously hypertensive rats. J Mol Cell Cardiol. 24:1992;317-321.
113. Koundakjian P.P., Turnbull D.M., Bone A.J., et al. Metabolic changes in fed rats caused by chronic administration of ethyl 2{5(4-chlorophenyl)pentyl}oxirane-2-carboxylate, a new hypoglycaemic compound. Biochem Pharmacol. 33:1984;465-473.
114. Kusaka Y., Tanaka T., Okamoto F., et al. Effect of sulfo-N-succinimidyl palmitate on the rat heart: Myocardial long-chain fatty acid uptake and cardiac hypertrophy. J Mol Cell Cardiol. 27:1995;1605-1612.
115. Aitman T.J., Glazier A.M., Wallace C.A., et al. Identification of CD36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature. 21:1999;76-83.
116. Nakamura T., Sugihara H., Inaba T., et al. CD36 deficiency has little influence on the pathophysiology of hypertrophic cardiomyopathy. J Mol Cell Cardiol. 31:1999;1253-1259.
117. Hwang E.H., Yamashita A., Takemori H., et al. Absent myocardial I-123 BMIPP uptake in a family. Ann Nucl Med. 10:1996;445-458.
118. Distel R.J., Robinson G.S., Spiegelman B.M. Fatty acid regulation of gene expression. Transcriptional and post-transcriptional mechanisms. J Biol Chem. 267:1992;5937-5941.
119. Grimaldi P.A., Knobel S.M., Whitesell R.R., Abumrad N.A. Induction of aP2 gene expression by nonmetabolized long-chain fatty acids. Proc Natl Acad Sci USA. 89:1992;10930-10934.
120. Jump B.D., Clarke S.D., Thelen A., Liimatta M. Coordinate regulation of glycolytic and lipogenic expression by polyunsaturated fatty acids. J Lipid Res. 35:1994;1076-1084.
121. Meunier-Durmort C., Poirier H., Niot I., Forest C. Upregulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids. Biochem J. 319:1996;483-487.
122. Van Bilsen M., Vork M.M., Van der Lee K.A.J.M., Willemsen P.H.M., Van der Vusse G.J. Fatty acid-mediated changes in neonatal cardiomyocyte gene expression. J Mol Cell Cardiol. 31:1999;A69.
123. Glatz J.F.C., Veerkamp J.H. Postnatal development of palmitate oxidation and mitochondrial enzyme activities in rat cardiac and skeletal muscle. Biochim Biophys Acta. 711:1982;327-335.
124. Lopaschuk G.D., Collins-Nakai R.L., Itoi T. Developmental changes in energy substrate use by the heart. Cardiovasc Res. 26:1992;1172-1180.
125. Van Nieuwenhoven F.A., Verstijnen C.P.H.J., Abumrad N.A., et al. Putative membrane fatty acid translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem Biophys Res Commun. 207:1995;747-752.
126. Gulick T., Cresci S., Caira T., Moore D.D., Kelly D.P. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA. 91:1994;11012-11016.
127. Gottlicher M., Widmark E., Li Q., Gustafsson J.A. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA. 89:1992;4653-4657.
128. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and γ Proc Natl Acad Sci USA. 94:1997;4312-4317.
129. Kliewer S.A., Sundseth S.S., Jones S.A., et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with proxisome proliferator-activated receptors α and γ Proc Natl Acad Sci USA. 94:1997;4318-4323.
130. Xu H.E., Lambert M.H., Montana V.G., et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell. 3:1999;397-403.
131. Braissant O., Foufelle F., Scotto C., Dauca M., Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs); tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology. 137:1996;354-366.
132. Guan Y.F., Zhang Y.H., Davis L., Breyer M.D. Expression of peroxisome proliferator-activated receptor in urinary tract of rabbits and humans. Am J Physiol. 273:1997;F1013-F1022.
133. Jones P.S., Savory R., Barratt P., et al. Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes. Eur J Biochem. 233:1995;219-226.
134. Kliewer S.A., Forman B.M., Blumberg B., et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA. 91:1994;7355-7359.
135. Spector A.A., John K., Fletcher J.E. Binding of long-chain fatty acids to bovine serum albumin. J Lipid Res. 10:1969;56-67.
136. Ockner R.K., Manning J.A., Poppenhausen R.B., Ho W.K. A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues. Science. 177:1972;56-58.